2. Park DD, Shin R, Kim JS, Oh HK, Jeong SY, Park KJ, et al. Clinical features of colorectal cancer detected by the national cancer screening program. J Korean Soc Coloproctol 2010;26:420–423. PMID:
21221243.
3. Edge SB. American Joint Committee on Cancer. AJCC cancer staging manual. 2010.7th ed. New York: Springer.
4. Cohen AM, Kelsen D, Saltz L, Minsky BD, Nelson H, Farouk R, et al. Adjuvant therapy for colorectal cancer. Curr Probl Surg 1997;34:601–676. PMID:
9251585.
5. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352–358. PMID:
2300087.
6. Stipa S, Nicolanti V, Botti C, Cosimelli M, Mannella E, Stipa F, et al. Local recurrence after curative resection for colorectal cancer: frequency, risk factors and treatment. J Surg Oncol Suppl 1991;2:155–160. PMID:
1892525.
7. Blumberg D, Paty PB, Picon AI, Guillem JG, Klimstra DS, Minsky BD, et al. Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg 1998;186:574–579. PMID:
9583699.
8. Willett CG, Lewandrowski K, Donnelly S, Shellito PC, Convery K, Eliseo R, et al. Are there patients with stage I rectal carcinoma at risk for failure after abdominoperineal resection? Cancer 1992;69:1651–1655. PMID:
1551050.
9. Sticca RP, Rodriguez-Bigas M, Penetrante RB, Petrelli NJ. Curative resection for stage I rectal cancer: natural history, prognostic factors, and recurrence patterns. Cancer Invest 1996;14:491–497. PMID:
8816864.
10. Wichmann MW, Müller C, Hornung HM, Lau-Werner U, Schildberg FW. Colorectal Cancer Study Group. Results of long-term follow-up after curative resection of Dukes A colorectal cancer. World J Surg 2002;26:732–736. PMID:
12053228.
11. Steinberg SM, Barwick KW, Stablein DM. Findings from the Gastrointestinal Tumor Study Group. Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Cancer 1986;58:1340–1345. PMID:
3742458.
12. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg 2006;93:1115–1122. PMID:
16804870.
13. Michelassi F, Vannucci L, Montag A, Goldberg R, Chappell R, Dytch H, et al. Importance of tumor morphology for the long term prognosis of rectal adenocarcinoma. Am Surg 1988;54:376–379. PMID:
3377331.
14. Choi PW, Yu CS, Jang SJ, Jung SH, Kim HC, Kim JC. Risk factors for lymph node metastasis in submucosal invasive colorectal cancer. World J Surg 2008;32:2089–2094. PMID:
18553050.
15. Hori H, Fujimori T, Fujii S, Ichikawa K, Ohkura Y, Tomita S, et al. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma. Dis Colon Rectum 2005;48:938–945. PMID:
15785891.
16. Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum 2002;45:628–634. PMID:
12004212.
17. Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993;36:627–635. PMID:
8348847.
18. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40:127–132. PMID:
11952856.
19. Müller JM, Tübergen D, Zieren U. After-care in colorectal cancer-data and patient oriented evaluation. Zentralbl Chir 1994;119:65–74. PMID:
7513117.
20. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994;73:2076–2082. PMID:
8156513.
21. Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698–702. PMID:
4041728.
22. Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Potentially curative surgery of colon cancer: the influence of blood vessel invasion. J Clin Oncol 1988;6:119–127. PMID:
2826712.
23. Horn A, Dahl O, Morild I. The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum 1990;33:598–601. PMID:
2361429.
24. Lim SB, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum 2010;53:377–384. PMID:
20305435.
25. Park IJ, Kim HC, Yu CS, Kim JC. Pattern of recurrences and metastases after a curative resection for primary colorectal cancer. J Korean Soc Coloproctol 2008;24:207–213.
26. Griesenberg D, Nürnberg R, Bahlo M, Klapdor R. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Anticancer Res 1999;19(4A): 2443–2450. PMID:
10470173.
27. Steele G Jr. Follow-up plans after treatment of primary colon and rectum cancer. World J Surg 1991;15:583–588. PMID:
1949855.
28. Aghili M, Izadi S, Madani H, Mortazavi H. Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer. Asia Pac J Clin Oncol 2010;6:35–41. PMID:
20398036.